The activation and upregulation of BCAA transaminase 1 (BCAT1), a cytosolic aminotransferase for branched-chain amino acids (BCAA), by Musashi2 is functionally needed for CML progression and metabolic reprogramming. This evidence concerns the gene BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.